Sanovel İlaç
Murat Gümrükcü has extensive work experience in the pharmaceutical industry. Murat is currently employed at Sanovel İlaç as the Business Excellence & Digital Transformation Director since February 2021. Prior to this, they worked at Nobel İlaç as the Sales Force Effectiveness Senior Manager from April 2017 to February 2021. Murat also had significant roles at Teva Pharmaceuticals, including EMIA APAC Regional Lead, Sales Force Effectiveness & Turkey Commercial Excellence Head from April 2012 to April 2017, and Head of Sales Force Effectiveness Middle East, North Africa, and Turkey from May 2010 to April 2012. Before joining Teva Pharmaceuticals, they held the position of Commercial Excellence Head at Allergan from March 2010 to May 2010. Murat also gained experience at Sandoz as a Sales Force Effectiveness Manager from December 2006 to March 2010 and at Bilim İlaç as a Sales Force Effectiveness Senior Specialist from May 2003 to December 2006. Murat began their career as a Medical Sales Representative at Bilim İlaç in June 1999 and held this position until May 2003.
Murat Gümrükcü earned a Bachelor's degree in International Relations from Istanbul University, which they completed between 1991 and 1996. Murat also obtained various certifications, including Qlikview Business Intelligence end-user & Developer program from Qlik, Microsoft Excel advanced VBA from Bilge Adam, Business Analytics from data to insights program from Wharton Executive Education, Data Mining Expert from ODTÜ, Veeva Admin certification from Accenture, and EFT Master from AMT. The specific months of when they obtained these certifications are not provided.
This person is not in any teams
This person is not in any offices
Sanovel İlaç
Sanovel, which produces at world standards without making any concessions to its principles and quality, was founded by Pharmacist Erol Toksöz. Having set up Ankara Galenos Pharmaceutical Warehouse in 1971, which is a step into the pharmaceutical industry, he purchased Adilna in 1982. He established Sanovel in 1983. Having started its production in Şişli, Sanovel today brings Turkish pharmaceutical industry to the future at modern facilities with an indoor space of 53,000 m2, located on an area of 125,000 m2. Having made a quick and stable improvement since its foundation, Sanovel is one of the leading companies in the pharmaceutical industry. Sanovel Pharmaceutical’s production facility, first laid foundation at İstanbul Silivri Çantaköy in 2001, fully started production as of November 2006. The production site comprises the main production unit, cephalosporin production unit, refining unit, elevated storage and social recreational facility. The production capacity is 227 million units per year. Closely following the developments in the world, Sanovel sets an example for the whole Turkish pharmaceutical industry, with the huge investments it makes in human resources and Research & Development studies.